These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 23370186

  • 1. Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru.
    Goldie SJ, Levin C, Mosqueira-Lovón NR, Ortendahl J, Kim J, O'Shea M, Diaz Sanchez M, Mendoza Araujo MA.
    Rev Panam Salud Publica; 2012 Dec; 32(6):426-34. PubMed ID: 23370186
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J, Bogaards JA, Demirel E, Diaz M, Sharma M, Kim JJ.
    Vaccine; 2013 Dec 31; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [Abstract] [Full Text] [Related]

  • 3. Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis.
    Messoudi W, Elmahi T, Nejjari C, Tachfouti N, Zidouh A, Saadani G, Moriña D, Diaz M.
    J Med Econ; 2019 Nov 31; 22(11):1153-1159. PubMed ID: 31135231
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand.
    Sharma M, Ortendahl J, van der Ham E, Sy S, Kim JJ.
    BJOG; 2012 Jan 31; 119(2):166-76. PubMed ID: 21481160
    [Abstract] [Full Text] [Related]

  • 5. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.
    Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ.
    Vaccine; 2015 Jun 04; 33(24):2830-41. PubMed ID: 25770785
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India.
    Diaz M, Kim JJ, Albero G, de Sanjosé S, Clifford G, Bosch FX, Goldie SJ.
    Br J Cancer; 2008 Jul 22; 99(2):230-8. PubMed ID: 18612311
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan.
    Tang CH, Cheng WF, Jiang JH, You SL, Huang LW, Hsieh JY, Mukherjee P, Van Kriekinge G, Lee C.
    Asian Pac J Cancer Prev; 2019 May 25; 20(5):1377-1387. PubMed ID: 31127896
    [Abstract] [Full Text] [Related]

  • 12. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T, Lutsar K, Uusküla A, Padrik L, Raud T, Reile R, Nahkur O, Kiivet RA.
    Vaccine; 2017 Nov 01; 35(46):6329-6335. PubMed ID: 28899625
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.